CS276924B6 - Agent preventing the formation of dandruff in the form of emulsion or shampoo - Google Patents
Agent preventing the formation of dandruff in the form of emulsion or shampoo Download PDFInfo
- Publication number
- CS276924B6 CS276924B6 CS47790A CS47790A CS276924B6 CS 276924 B6 CS276924 B6 CS 276924B6 CS 47790 A CS47790 A CS 47790A CS 47790 A CS47790 A CS 47790A CS 276924 B6 CS276924 B6 CS 276924B6
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- dandruff
- emulsion
- shampoo
- formation
- image
- Prior art date
Links
- 208000001840 Dandruff Diseases 0.000 title claims description 11
- 239000000839 emulsion Substances 0.000 title claims description 10
- 239000002453 shampoo Substances 0.000 title claims description 9
- 239000003795 chemical substances by application Substances 0.000 title description 3
- 230000015572 biosynthetic process Effects 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims description 19
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 150000002169 ethanolamines Chemical class 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- NNGAOWIGWWRQIJ-UHFFFAOYSA-N 1-(2,4,4-trimethylpentyl)pyridin-2-one Chemical compound CC(C)(C)CC(C)CN1C=CC=CC1=O NNGAOWIGWWRQIJ-UHFFFAOYSA-N 0.000 claims 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims 1
- 239000000463 material Substances 0.000 abstract 3
- 230000005855 radiation Effects 0.000 abstract 2
- 239000010410 layer Substances 0.000 abstract 1
- 239000002985 plastic film Substances 0.000 abstract 1
- 229920006255 plastic film Polymers 0.000 abstract 1
- 239000011241 protective layer Substances 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 4
- 229940081510 piroctone olamine Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229940043810 zinc pyrithione Drugs 0.000 description 4
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 2
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- QTDIEDOANJISNP-UHFFFAOYSA-N 2-dodecoxyethyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOCCOS(O)(=O)=O QTDIEDOANJISNP-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- WPZSJJJTNREFSV-UHFFFAOYSA-N [Zn].[O-][N+]1=CC=CC=C1S Chemical compound [Zn].[O-][N+]1=CC=CC=C1S WPZSJJJTNREFSV-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007682 dermal toxicity Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical class CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 238000011418 maintenance treatment Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- YBBJKCMMCRQZMA-UHFFFAOYSA-N pyrithione Chemical compound ON1C=CC=CC1=S YBBJKCMMCRQZMA-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 231100000438 skin toxicity Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000011269 tar Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
Vynález se týká prostředku proti tvorbě lupů ve formě emulze a šamponu. Emulzní přípravek se aplikuje při silných formách choroby a šampon je spíše užíván při udržovacích kůrách nebo při lehčích formách choroby. Oba přípravky se vyznačují vysokou účinností, zejména při jejich vzájemné kombinaci.The present invention relates to an anti-dandruff composition in the form of an emulsion and a shampoo. The emulsion formulation is applied in severe forms of the disease and the shampoo is more commonly used in maintenance treatments or lighter forms of the disease. Both formulations are characterized by high efficacy, especially when combined with each other.
Cílem vynálezu je zamezení nebo podstatné snížení tvorby lupů použitím kombinace emulzního přípravku (který se nanáší na několik hodin, nejlépe přes noc na pokožku hlavy) a vlasového šamponu.It is an object of the invention to prevent or substantially reduce dandruff by using a combination of an emulsion formulation (which is applied for several hours, preferably overnight to the scalp) and hair shampoo.
V obou přípravcích je dosaženo vysoké účinnosti proti lupům použitím kombinace zinečnatého komplexu 2-pyridinthiol-i-oxidu (dále zink-pyrithionu) a monoethanolaminové soliIn both formulations, high anti-dandruff efficacy is achieved by using a combination of zinc 2-pyridinthiol-i-oxide (hereinafter zinc-pyrithione) and monoethanolamine salt
1- hydroxy-4-methyl-6-(2,4,4-trimethylpetyl)-2(1H)-pyridonu (dále jen pirocton olaminu), při které se projeví synergické účinky.1-hydroxy-4-methyl-6- (2,4,4-trimethylpetyl) -2 (1H) -pyridone (hereinafter piroctone olamine), which exhibits synergistic effects.
Doposud používané látky proti lupům využívají působení celé řady látek jako jsou různé dehty, selendisulfid, deriváty kyseliny undecylenové, salicylové, zinečnaté, hořečnaté a sodné soliThe anti-dandruff agents used hitherto use a wide range of substances such as various tars, selendisulfide, undecylenic acid, salicylic acid, zinc, magnesium and sodium salts.
2- pyridinthiol-l-oxidu, monoethanolaminové soli l-hydrosy-4-methyl-6-(2,4,4-trimethylpentyl)-2(1H)-pyridonu a j iné. Použití těchto látek je popsáno v literatuře příslušných firem vyrábějících tyto látky jako například fy Olin Chemicals USA, Hoechst SRN, Rewo SRN a jiné. Dále je použití těchto látek popsáno v encyklopediích kosmetické chemie jako například Cosmetics2-pyridinethiol-1-oxide, monoethanolamine salts of 1-hydrose-4-methyl-6- (2,4,4-trimethylpentyl) -2 (1H) -pyridone and others. The use of these substances is described in the literature of the respective companies producing these substances, such as Olin Chemicals USA, Hoechst Germany, Rewo Germany and others. Further, the use of these substances is described in cosmetic chemistry encyclopedias such as Cosmetics
M.S.Balsama a E.Sagarina (Willex, New York 1972), Handbuch der Kosmetika und Riechstoffe od H.Janistyna (Húthig Verlag, Heidelberg 1973), Die Kosmetische Práparate od G.A.Nowaka (Ziolkowski, Augsbur 1969) a jiné. V žádné z těchto publikací není popsáno současné použití těchto dvou látek a nebo kombinace dvou protilupových přípravků. Nevýhodou některých těchto látek je jejich vysoká toxicita (zejména selendisulfid) nebo poměrně nízká účinnost vedoucí k používání vysokých koncentrací, způsobujících nežádoucí vedlejší účinky, zejména zvýšenou tvorbou kožního mazu.M.S.Balsama and E.Sagarin (Willex, New York 1972), Handbuch der Kosmetika und Riechstoffe by H. Janistyn (Hüthig Verlag, Heidelberg 1973), Die Kosmetische Praparate by G. A. Nowak (Ziolkowski, Augsbur 1969) and others. None of these publications disclose the simultaneous use of the two agents or a combination of the two anti-drug preparations. The disadvantage of some of these substances is their high toxicity (especially selendisulfide) or relatively low efficacy resulting in the use of high concentrations causing undesirable side effects, in particular increased sebum production.
Uvedené nedostatky odstraňuje vynález týkající se prostředku proti tvorbě lupů ve formě emulze nebo šamponu, kde je použito zink-pyrithionu a pirocton olaminu. Podle výsledků našich výzkumů se projeví synergické působení a je dosaženo dobré protilupové účinnosti při poměrně nízkých koncentracích obou aktivních látek. Protilupové látky jsou součástí krému typu olej ve vodě a vlasového šamponu. Praktické zkoušky (u 60 případů ložiskové a difusní seborrhoey dvojitým slepým pokusem a porovnávané placebem) potvrdily, že přípravky připravené a použité podle vynálezu mají překvapující účinnost. Během zkoušek přípravků (na 38 dobrovolnících s epikuánním testováním) nebyly zaznamenány žádné nepříznivé alergické reakce a nebo známky dermální toxicity.These drawbacks are overcome by the invention relating to an anti-dandruff composition in the form of an emulsion or shampoo, wherein zinc pyrithione and piroctone olamine are used. According to the results of our research, a synergistic effect is shown and good anti-dull activity is achieved at relatively low concentrations of both active substances. The anti-husk ingredients are part of an oil in water cream and hair shampoo. Practical tests (in 60 cases of focal and diffuse seborrhoea by double blind and compared with placebo) confirmed that the formulations prepared and used according to the invention have surprising efficacy. No adverse allergic reactions or signs of dermal toxicity were observed during the trials (38 volunteers with epiculum testing).
Použití vynálezu je zřejmé z následujících příkladů.The use of the invention is evident from the following examples.
Příklad 1.: Emulzní přípravek proti lupům.Example 1: Anti-dandruff emulsion.
Směs 6 g cetylalkoholu, 12 g glycerolmonostearátu, 2 g isopropyl-myristátu, 10 g minerálního oleje, 4 g ethoxylovaného lauryl-myristylalkoholu (HLB = 17,3) se zahřeje na teplotu 75 °C. Tato směs tvoří tukovou fázi emulzního přípravku. K této směsi seA mixture of 6 g of cetyl alcohol, 12 g of glycerol monostearate, 2 g of isopropyl myristate, 10 g of mineral oil, 4 g of ethoxylated lauryl-myristyl alcohol (HLB = 17.3) is heated to 75 ° C. This mixture forms the fat phase of the emulsion formulation. To this mixture is added
pomalu za míchání přidá směs 2,5 g 48 % hmot. suspenze zink-pyrithionu ve vodě a 0,05 g 1,5 % hmot. vodného roztoku směsi 5-chlor-2-methyl-4-isothiazolin-3-onu a 2-methyl-4-isothiazolin-3-onu a 62,85 g vody zahřáté na 75 °C. Po přidání a vzniku emulze se k horké emulzi přidá roztok 0,1 g piroctonu olaminu v 1 g 96 % obj. ethanolu. Směs se míchá za volného chlazení do teploty 28 °C, kdy vznikne měkký krém, vyznačující se výbornými protilupovými účinky.2.5 g of 48 wt. % suspension of zinc-pyrithione in water and 0.05 g of 1.5 wt. aqueous solution of a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one and 62.85 g of water heated to 75 ° C. After addition and formation of the emulsion, a solution of 0.1 g of piroctone olamine in 1 g of 96% v / v ethanol is added to the hot emulsion. The mixture is stirred under free cooling to 28 ° C to form a soft cream characterized by excellent anti-dandruff effects.
Příklad 2.: Šampon proti lupům.Example 2: Anti-dandruff shampoo.
Směs 10 g 29 % hmot. roztoku laurylethersulfátu sodného,Mixture 10 g 29% wt. sodium lauryl ether sulphate solution,
1,1 g karboxymethylcelulozy, 5 g diethanolamidu kokosových mastných kyselin, 0,1 g rozpustného elastinu, 0,05 g 1,5 % hmot. vodného roztoku směsi 5-chlor-2-methyl-4-isothiazolin-3-onu a 2-methyl-4-isothiazolin-3-onu, 1,05 g 48 % hmot. suspenze zink-pyrithionu ve vodě, 0,1 g vonné kompozice a 0,1 g pirocton olaminu se míchá do vzniku homogenní směsi. Ke směsi se dále přidá 71,30 g vody, ve které je rozpuštěno 0,2 g kyseliny citrónové a 2 g chloridu sodného. Vzniklá směs se opět míchá do úplné homogenity, kdy se k ní přidá 9 g 35 % hmot. roztoku alkylamidobetainu, čímž dojde ke konečnému vzestupu viskozity. Takto připravený šampon má velmi šetrné účinky na vlasy a velmi dobrou účinnost proti lupům.1.1 g carboxymethylcellulose, 5 g coconut fatty acid diethanolamide, 0.1 g soluble elastin, 0.05 g 1.5 wt. of an aqueous solution of a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one, 1.05 g of 48 wt. a suspension of zinc-pyrithione in water, 0.1 g of the fragrance composition and 0.1 g of piroctone olamine are mixed to form a homogeneous mixture. 71.30 g of water, in which 0.2 g of citric acid and 2 g of sodium chloride are dissolved, are added. The resulting mixture is again mixed to complete homogeneity by adding 9 g of 35 wt. of an alkylamidobetaine solution, resulting in a final increase in viscosity. This shampoo has a very gentle effect on the hair and very good anti-dandruff effect.
Účinnost obou druhů přípravků byla prokázána dvojitě slepým pokusem u 38 dobrovolníků.The efficacy of both product types was demonstrated by a double blind trial in 38 volunteers.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS47790A CS276924B6 (en) | 1990-02-01 | 1990-02-01 | Agent preventing the formation of dandruff in the form of emulsion or shampoo |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS47790A CS276924B6 (en) | 1990-02-01 | 1990-02-01 | Agent preventing the formation of dandruff in the form of emulsion or shampoo |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS9000477A2 CS9000477A2 (en) | 1991-08-13 |
| CS276924B6 true CS276924B6 (en) | 1992-09-16 |
Family
ID=5336935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS47790A CS276924B6 (en) | 1990-02-01 | 1990-02-01 | Agent preventing the formation of dandruff in the form of emulsion or shampoo |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS276924B6 (en) |
-
1990
- 1990-02-01 CS CS47790A patent/CS276924B6/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS9000477A2 (en) | 1991-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2234009C3 (en) | Cosmetic preparations | |
| EP0238167B1 (en) | Dye-conditioner composition and method | |
| DE3712005C2 (en) | Cosmetic preparations and methods for dyeing or decolorizing hair | |
| US6537533B2 (en) | Hair conditioner composition that is non-irritating to the eyes | |
| US20020168327A1 (en) | Treatment of dandruff | |
| US4307089A (en) | Compositions of pyrithione metal salts and undecylenic acid alkylolamide derivatives | |
| US4529588A (en) | Hair conditioning shampoo | |
| JP6849697B2 (en) | How to treat hair disorders with N-hydroxypyridinone | |
| CZ271798A3 (en) | Skin toning composition | |
| BRPI0616042B1 (en) | shampoo containing a gel network | |
| DE2151740A1 (en) | HAIR COSMETIC AGENTS | |
| JP2023528082A (en) | Synergistic anti-inflammatory composition | |
| JPH0238564B2 (en) | ||
| EP0646369B1 (en) | Cosmetic compositions comprising 1-hydroxy-2-pyridones as antidandruff and deodorant agents | |
| JPH07504911A (en) | mild shampoo composition | |
| RS49801B (en) | APPLICATION OF 1-HYDROXY-2-pyridone for the treatment of seborrheic dermatitis | |
| CS276924B6 (en) | Agent preventing the formation of dandruff in the form of emulsion or shampoo | |
| JPH0460571B2 (en) | ||
| JP2000129298A (en) | Detergent composition | |
| EP0260697B1 (en) | Composition for application to hair | |
| JP2696523B2 (en) | Anti-dandruff agent and hair cosmetic | |
| US4728667A (en) | Hair treatment composition for prevention of dandruff in hair | |
| US4155994A (en) | Hair conditioning agents | |
| JP2860124B2 (en) | Hair cosmetics | |
| CZ20014706A3 (en) | Cosmetic method of skin care |